Pemetrexed-free vs. Pemetrexed-based Immunochemotherapy in Metastatic TTF-1 Negative Lung Adenocarcinoma
Clinical trial NCT05689671 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05689671
- Sponsor
- Nikolaj Frost MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-06
- Primary completion
- 2026-03-05
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.